Clinical Trials Browser

Phase 2 × Neuroectodermal Tumors, Primitive, Peripheral × Gemcitabine × Clear all

NCT00073983 2012-03-12

Gemcitabine and Docetaxel in Treating Patients With Recurrent Osteosarcoma (Closed to Accrual as of 12/21/06) or Ewing's Sarcoma or Unresectable or Locally Recurrent Chondrosarcoma

Phase 2 Completed

54 enrolled 8 charts

Chondrosarcoma, Sarcoma, Osteosarcoma, Neuroectodermal Tumors, Primitive, Peripheral